FDA Investigator Jose A Cruz

Jose A Cruz has inspections in 8 countries as of 03 Nov 2023. Jose A Cruz has collaborated with a combinined 2685 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
32
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100007359
Country:
Switzerland, United States of America, Spain, Canada, France, Germany, Puerto Rico, Japan
Co-Investigator(s):
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan A Rivera, Anastasia G Lolas, Angelica M Hernandez, Ann L Demarco, Ann Marie Montemurro, Annette Melendez, Ariel Cruz Figueroa, Arlene M Badillo, Arsen Karapetyan, Barbara M Frazier, Brandon C Heitmeier, Brenda Rivera, Carl A Anderson, Carlos A Medina, Cassandra L Abellard, CDR Ileana Barreto Pettit, Charles I Ann, Charles M Edwards, Cheryl A Clausen, Constance Y Fears, Dayna I Martinez, Doan T Nguyen, PharmD, Don H Bark, PhD, Douglas C Kovacs, Edwin Martinez, Eliezar Ramos, German Rivera, Gloria E Parra, Gwyn G Dickinson, Helen B Ricalde, Iraida Ortiz, Ivis L Negron, Ivis Lnegron Torres, James L Dunnie, Jr, James P Mcevoy, Jason K Morgan, Javier O Vega, Jeffrey A Sommers, Jeffrey B Medwid, PhD, Joey V Quitania, John P Mistler, Jorge E Martinez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose Acruz Gonzalez, Jose Alopez Rubet, José E Meléndez, Jose E Melendez, DDC, Jose F Pedro, Jose Fpedrode Jesus, Jose R Lopez, Jose Rflores Veguilla, Jose Rflores Vequilla, Jose Velez, Julie D Bringger, Karl D Hezel, Katherine E Jacobitz, Kathleen D Culver, Kenneth H Williams, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Kim Lthomas Cruse, Kip J Hanks, Kristina L Conroy, Laiza V Garcia, Laura E Garcia, Laurimer Kuilan Torres, Libia M Lugo, Lisa M Bellows, Lourdes Andujar, Luella J Rossi, Luis Soto Lopez, Maria A Ruttell, Marian E Ramirez, Marie A Fadden, Marie F Morin, Marilyn Santiago, Matthew B Casale, Maxwell Van Tassell, PhD, Michael E Maselli, Michael Levy, Michael R Goga, Michele L Obert, Michelle Y Clark Stuart, Miguel A Martinez, Milva E Melendez, Min Tang, Minh D Phan, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nancy G Schmidt, Nancy N Bellamy, Noreen Muniz, Omotunde O Osunsanmi, Pablo Feliciano, Paraluman S Leonin, Parul M Patel, Patricia Fhughes Troost, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Peter R Lenahan, Prabhu P Raju, Rafael Nevarez Nieves, Ralph H Vocque, Ramesh Potla, PhD, Ramon A Hernandez, Raquel Gonzalez Rivera, Raymond T Oji, Rebeca M Melendez, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Robert C Coleman, Robert C Steyert, Robert J Martin, Robert Q Jennings, Robert W Jennings, Russell J Glapion, Sangeeta M Khurana, PhD, Sharon K Thoma, PharmD, Sidney B Priesmeyer, Sixto M Mercado, Sixto M Mercado Rios, Sonia M Monges, Stephanie D Crockett, Stephen D Brown, Steven B Barber, Susan O Oladeji, Thomas E Friel, Thomas J Arista, Thomas W Nojek, Uttaniti Limchumroon (Tom), Victor J Gangi, Vilmary Negron Rodriguez, Wanda J Torres, Yanming An, PhD, Yasamin Ameri, Yumi J Hiramine, Zhong Li, PhD

Jose A Cruz's Documents

Publish Date Document Type Title
May, 2003 FDA 483 Bristol-Myers Squibb Manufacturing Company - Form 483, 2003-05-09
April, 2000 FDA 483 CIBA Vision Ophthalmics - Form 483, 2000-04-18
April, 2000 EIR OMJ Pharmaceuticals, Inc. - EIR, 2000-04-18
October, 2003 FDA 483 Antibiotics SA - Form 483, 2003-10-22
March, 2000 EIR Bristol-Myers Squibb Manufacturing Company - EIR, 2000-03-21
October, 2004 FDA 483 Bayer AG - Form 483, 2004-10-22
February, 2002 FDA 483 Contract Pharmaceutical Limited - Form 483, 2002-02-20
July, 2010 FDA 483 Yuki Gosei Kogyo Co., Ltd. - Form 483, 2010-07-21
August, 2006 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2006-08-07
October, 2000 FDA 483 Novartis Pharma AG - Form 483, 2000-10-19
February, 2008 FDA 483 Warner Chilcott Company, LLC - Form 483, 2008-02-05
December, 2003 EIR Bristol Myers Squibb Caribbean Company - EIR, 2003-12-17
October, 2000 EIR Novartis Pharma Ag - EIR, 2000-10-19
October, 2003 FDA 483 Towa Pharmaceutical Europe, S.L. - Form 483, 2003-10-29
September, 2001 FDA 483 OMJ Pharmaceuticals, Inc. - Form 483, 2001-09-14
August, 2002 FDA 483 Bristol-Myers Squibb Manufacturing Company - Form 483, 2002-08-01
April, 2000 FDA 483 Response OMJ Pharmaceuticals, Inc. - Form 483R, 2000-05-03
May, 2002 FDA 483 Lilly Del Caribe, Inc. - Form 483, 2002-05-13
October, 2000 EIR Novartis Pharma AG - EIR, 2000-10-30
December, 2006 FDA 483 Ortho Biologics LLC - Form 483, 2006-12-07
August, 2005 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2005-08-31
October, 2000 FDA 483 Novartis Pharma S.A. - Form 483, 2000-10-26
October, 2000 FDA 483 Novartis Pharma AG - Form 483, 2000-10-30
May, 2002 EIR Lilly Del Caribe, Inc. - EIR, 2002-05-13
March, 2003 EIR Bristol Myers Squibb Caribbean Company - EIR, 2003-03-31
February, 2002 FDA 483 Response Contract Pharmaceuticals Limited Canada - Form 483R, 2002-04-02
September, 2002 EIR Pfizer Pharmaceutical Llc. - EIR, 2002-09-18
October, 2003 FDA 483 MOEHS Catalana, S.A. - Form 483, 2003-10-24
October, 2003 EIR Towa Pharmaceutical Europe, S.L. - EIR, 2003-12-22
November, 2002 FDA 483 Senn Chemicals AG - Form 483, 2002-11-21
May, 2009 FDA 483 Ortho Biologics LLC - Form 483, 2009-05-04
August, 2002 EIR Bristol-Myers Squibb Manufacturing Company - EIR, 2002-08-01
September, 2001 EIR OMJ Pharmaceuticals, Inc. - EIR, 2002-03-19
November, 2002 FDA 483 Response Senn Chemicals AG - Form 483R, 2002-12-20
February, 2005 FDA 483 Boehringer Ingelheim Animal Health Puerto Rico LLC - Form 483, 2005-02-16
October, 2004 EIR Bayer AG - EIR, 2004-11-29
February, 2002 EIR Contract Pharmaceuticals Limited Canada - EIR, 2002-02-20
October, 2004 FDA 483 Response Bayer AG - Form 483R, 2004-11-17
September, 2002 FDA 483 Response Pfizer Pharmaceutical Llc. - Form 483R, 2002-10-10
August, 2006 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2006-08-31
October, 2000 FDA 483 Confarma AG - Form 483, 2000-10-31
September, 2002 FDA 483 Pfizer Pharmaceutical Llc. - Form 483, 2002-09-18
May, 2003 EIR Bristol-Myers Squibb Manufacturing Company - EIR, 2003-05-09
August, 2006 EIR Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - EIR, 2006-08-07
July, 2003 FDA 483 Mayne Pharma (PR) Inc. - Form 483, 2003-07-17
December, 2003 FDA 483 Bristol Myers Squibb Caribbean Company - Form 483, 2003-12-17
November, 2002 EIR Senn Chemicals AG - EIR, 2002-11-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more